Dechra Veterinary Products, maker of the feline hyperthyroidism treatment Felimazole®, has launched a range of waiting room materials for practices to raise awareness with owners about the disease.
Using Dechra's cartoon cat, which already features in their client booklets on feline hyperthyroidism, the materials are intended to create a focal point in the waiting room, with factual posters detailing what feline hyperthyroidism is and the symptoms to look out for. Also included is a selection of display enhancers.
The new waiting room display has been designed to complement Dechra's existing materials: client booklets, the website www.hyperthyroidcat.co.uk, website posters and hand-out cards.
Matthew Olsen, product manager at Dechra Veterinary Products said: "Our complete range of materials makes it easier for practices to communicate with owners on the subject and will help owners better understand and manage hyperthyroidism in their cats".
Practices can order their pack of waiting room materials by contacting Dechra on 01743 441632 or email marketing@dechra.com.
The RSPCA has reported a dramatic increase in the number of cats being abandoned.
The number of abandonments reported to the RSPCA was 10,610 in 2010, a 28% increase on the number reported in 2009 (8,310), and a 40% increase on the number in 2008 (7,609).
The charity received 205 reports of cats being shot in 2010, more or less the same as the year before. However, the charity says anecdotal reports suggest the number of cats being attacked (including being set upon by dogs or thrown from buildings) is increasing.
RSPCA chief veterinary officer, Alastair Macmillan, said: "The news of massive rises in abandonments and other attacks is alarming and shows a frightening trend in cat abuse and neglect. We don't know why we are seeing such increases and hope that people are not starting to see cats as worthless things which can be targeted with weapons or just dumped when people don't want to care for them anymore".
Bayer Animal Health has announced the launch of, Dinalgen (ketoprofen), an NSAID injection approved for use in cattle, pigs and horses.
Dinalgen is available as a 150mg/ml Solution for Injection, and Bayer says the more concentrated format allows the product to provide the smallest dose, fast relief NSAID currently available for cattle in the UK.
In cattle, Dinalgen is licensed for the reduction of inflammation and pain associated with lameness, post-partum, and musculoskeletal disorders; the reduction of fever associated with bovine respiratory disease; and the reduction of inflammation, fever and pain in acute clinical mastitis in combination with antimicrobial therapy where appropriate. The withdrawal period for milk is zero hours and for meat two days.
In pigs, Dinalgen is licensed for the reduction of pyrexia in cases of respiratory disease and postpartum dysgalactia syndrome in sows, in combination with antimicrobial therapy.
In horses, Dinalgen is licensed for the reduction of inflammation and pain associated with osteoarticular and musculoskeletal disorders, including lameness, laminitis, osteoarthritis, synovitis, and tendinitis. It also aids the reduction of visceral pain associated with colic.
Sharon Cooksey, MRCVS, FAP group product manager at Bayer, said: “We are excited to have this new addition to our portfolio. It is a good fit with our existing products.
"A recent field study*, carried out by Nottingham university, has shown that NSAID (ketoprofen) treatment maximises the chance of recovery from lameness in dairy cattle. Lameness remains one of the “big three” issues in dairy practice so maybe it is time we moved on from hoof blocks and/ or trimming in isolation and onto a more multi-layer approach. We have some great support tools in the pipeline to help both vets and farmers recognise and manage animals at risk for lameness.”
For further product information visit www.noahcompendium.co.uk or contact your local Bayer territory manager.
The course is aimed at veterinary professionals across Europe who want to advance their knowledge and diagnostic skills, progress their academic qualifications and gain recognition in their field.
The GPAdvCert in Small Animal Medicine is for veterinary surgeons who have already completed a General Practitioner Certificate in Small Animal Medicine (GPCertSAM) or a Postgraduate Certificate (PgC) in Small Animal Medicine.
Accredited by the European School of Veterinary Postgraduate Studies (ESVPS) and validated by Harper Adams University, the programme will be delivered in three, five-day blocks of training by globally recognised experts in three European training centres - Sheffield, UK; Porto, Portugal and Berlin, Germany. The programme includes a practical session in which delegates will perform an upper and lower gastrointestinal endoscopy under the guidance of their tutor.
David Babington MRCVS, Business Development Director of Improve International (pictured right), said: "Delegates attending our first GPAdvCert in Small Animal Medicine will enhance their skills and confidence in dealing with complex animal medicine cases. Each module will take their knowledge beyond Postgraduate Certificate level with more in-depth and advanced content covering topics as diverse as mycobacterial and ureteric disease. They will also learn how to design a detailed diagnostic plan and build an understanding of nuances in interpreting laboratory findings to enable them to manage cases requiring complex therapeutic management with confidence."
He added: "The qualification is a natural ‘next-step’ for veterinary surgeons wanting to further progress their knowledge of small animal internal medicine. It will help them to reduce the number of patients which are referred, retaining a higher level of income for their practice and will also provide them with skills which they can pass onto their team."
Improve says the successful achievement of the GPAdvCert will enable delegates to progress from a Postgraduate Certificate in Small Animal Medicine (or equivalent) to the Postgraduate Diploma in Advanced Veterinary Practice Sciences in the UK, which is awarded by Harper Adams University. This can, in turn, be used towards the award of a Masters Degree (MSc) in Advanced Veterinary Practice Sciences.
To achieve the accreditation, Dechra’s Digital Learning team’s educational content, processes and services were reviewed and benchmarked against key opinion indicators by an LPI consultant.
Dechra Academy was first established in the UK in 2010 and has since launched in over 20 additional countries across the world.
Last year, over 5,000 veterinary professionals in the UK completed over 9,000 courses and there is currently over 60 hours of free CPD content available across the company’s therapy areas including endocrinology, dermatology, analgesia and anaesthesia, nutrition, equine analgesia and anaesthesia and locomotion.
The company has just launched the first of two courses in its ‘Purffect Partner’ series, which focuses on identifying and treating unintended feline weight loss.
A further four case studies will be added in the coming months.
www.dechra.co.uk/academy.
Intervet /Schering-Plough Animal Health has announced plans for a third National Vaccination Month Campaign to take place in May.
The campaign, which is aimed at owners of unvaccinated animals, is being fronted by TV presenter and wildlife expert Chris Packham. Intervet / Schering-Plough says it hopes the initiative will counter falling rates of pet vaccination that have been seen since the credit crunch.
In the lead up to National Vaccination Month, the company will be running a pet health awareness national and regional PR campaign backed up by print and TV advertising.
Pet owners will be able to download a voucher for a discounted vaccination in May from http://www.nvmonline.co.uk/. As well as dogs, cats and rabbits, horses will be included in the scheme for the second time.
During the last National Vaccination Month in June 2009, 1022 surgeries participated nationwide and an additional 40,000 animals were vaccinated as a result - 8,000 up on the first campaign run in 2008. According to Intervet / Schering-Plough, many practices saw more than 100 vouchers being redeemed.
The 2009 campaign came after more than a quarter of vets surveyed by Intervet reported concerns about falling levels of vaccination because of the credit crunch. Following the recession and public fears over the deficit, there are concerns that pet owners will cut back even further.
Angus Robinson from Intervet / Schering-Plough Animal Health said: "Research shows that the main reason why people don't vaccinate their pets is a lack of awareness of disease risk. We are also concerned that given the current pressures on household budgets, more people are deciding to cut back on vaccinating their animals with the real risk that this may have a potential effect on levels of herd immunity in the longer term."
He added: "We listened to practices which took part in NVM 2009 and have invested in improving the website to offer a simpler system for surgeries to download and log vouchers for their clients. The site will also drive pet owners to participating vets more quickly. Social media has taken off in a big way since our first campaign in 2008 and we will also be using Facebook and Twitter this time to reflect that. We are hoping that this will reach younger pet owners as data from our last campaign showed that pet owners in their 20s and early 30s were the age group least likely to vaccinate their animals."
Jane Carter of the Drove Veterinary Hospital in Swindon said: "National Vaccination Month is a golden opportunity to communicate the key preventative healthcare messages to new and existing clients. There was a significant outbreak of parvovirus in our area last summer which got a lot of publicity so we are expecting people will really catch onto the campaign this time."
Intervet / Schering-Plough Animal Health veterinary customers planning to take part in National Vaccination Month 2011 can log onto www.nvmonline.co.uk to complete the registration process.
The majority of posters, leaflets and other displays in veterinary practice waiting rooms are more effective at building ambience than increasing the turnover of the practice or selling a particular product or brand, according to a new survey carried out by veterinary marketing agency TMA.
The national survey of more than 100 veterinary practice managers found that:
TMA says it believes practices are missing out on a major marketing opportunity by not changing their displays more often, not being more selective about what is displayed, and not making the most of interactive or digital display technology.
Helen Cawthra, Managing Director of TMA believes that product manufacturers are also missing out on a major opportunity. Significantly less than half of all display and point-of-sale material in vets' waiting rooms is provided by suppliers. On average, 64% is sourced by the veterinary surgeons themselves.
Helen said: "Two thirds of respondents claim that they hardly get any materials from suppliers. The same number claim they would be more likely to put up more if they were provided with it.
"It is all very well building ambience and providing loyalty but in today's market, it is important that vets take hold of every opportunity to generate revenue in every way possible. Vets and the manufacturers are both missing out."
The forecast formed part of the Association's response to the Environment Food and Rural Affairs Committee (EfraCom) inquiry into the impact on the UK’s trade in food after Brexit.
The BVA says that if the UK is treated as a 'third country' post Brexit, exports and imports of animals and animal products to and from the EU will need new veterinary certifications.
The UK Chief Veterinary Officer, Nigel Gibbens, says the volume of products requiring veterinary certifications could increase by as much as 325% as a result.
There are currently 1,063 Official Veterinarians authorised by the Government’s Animal and Plant Health Agency (APHA) to certify food products for export to third countries from Great Britain, a number which the BVA says would have to be significantly increased.
The BVA is urging the Government to undertake a major review of third country certification to ensure we have the capacity to fulfil new trade agreements. To combat the potential shortage in veterinary capacity, BVA is also calling on the Government to guarantee working rights for non-British EU vets and veterinary nurses currently working and studying in the UK.
British Veterinary Association Senior Vice President, Gudrun Ravetz said: "Vets are absolutely vital to facilitating UK trade by ensuring standards so that consumers at home and abroad have confidence in the food safety and welfare of the products they choose to buy. Veterinary certification is required not only for meat, but a whole range of products such as gelatine in sweets.
"Ironically, it is non-British EU vets who make up around 50% of our new workforce each year. However, since the EU referendum, we are facing serious problems in recruiting and retaining EU vets, which makes the need for more vets to perform this crucial trade-task an even more pressing concern. Vets’ role in the future of UK trade must be recognised and planned for, as an integral part of forthcoming trade negotiations."
The BVA trade submission also outlines that access to veterinary medicines could potentially be restricted post-Brexit. In order to protect animal and public health, BVA is calling for any new trade deal with the EU to maintain the link with EU veterinary medicine approval systems.
The UK currently has high standards of animal health, animal welfare and public health, including food safety, in its food production. These standards help prevent the spread of pathogens and diseases in animal products, ensure farm animals have a humane death, protect food safety and safeguard responsible antimicrobial use. BVA’s submission to the EfraCom trade inquiry emphasises that, as public goods, the UK must prioritise the maintenance of these standards in all trade negotiations moving forwards.
BVA’s full response to the EfraCom inquiry into the impact on the UK’s trade in food after Brexit is available on the BVA website at www.bva.co.uk/news-campaigns-and-policy/consultations/consultation-responses/
The poster gives information about things like lillies, chocolate, raisins, fertilisers, weedkillers and adders.
TVM will also be running its annual social media campaign about the most common spring dangers, giving practices digital content which they can share with clients.
To get a poster for your practice, contact your local TVM territory manager or visit https://www.tvm-uk.com/pet-dangers-order-free-display-materials-for-your-practice.
Amongst other things, the plans offer 24/7 telephone counselling from GPs and trained counsellors.
Simplyhealth Professional’s Head Veterinary Officer, Gudrun Ravetz (pictured right), said: "Veterinary practice is a 24/7 job and it can be difficult for the veterinary team to access GP and counselling appointments during the day and of course, a mental or physical health crisis can hit at any time of the day or night. Access to the telephone care line ensures staff can freely access potentially life-saving advice and support at their time of greatest need, no matter when or where."
Optimise health plans also include access to the online myWellbeing portal which offers advice on a range of subjects, including childcare and eldercare responsibilities, finance and legal issues.
The plans also provide employees with free health evaluation tools and cashback on services including sight tests, dental treatment, diagnostics, physiotherapy and even prescription costs.
Lastly, Optimise health plans encourage leisure activities by offering discounts on sports equipment, gym membership and healthy family days out.
Gudrun added: "By providing access to talking therapies and removing some of the barriers to self-care, the Simplyhealth Optimise plans aim to support practices who want to ensure their staff can easily access the tools they need to maintain a healthy mind and body. Knowing that your practice cares enough about your wellbeing to put a care plan in place is very attractive to new recruits and existing staff alike."
Practice owners and managers can find out more by talking to their Simplyhealth Professionals Business Consultant, visit www.simplyhealthprofessionals.co.uk or call 0800 328 3233.
Maeve Cuffe, Junior Brand Manager of large animal products, at Forte Healthcare Ltd said: “As dairy herds increase in size, routine fertility visits result in larger numbers of cows requiring prostaglandin treatment.
"Also, some vets now recommend two shots of prostaglandin instead of one in certain synchronisation protocols.
"The 25 dose presentation of Genestran is a great addition to the range, helping vets keep enough prostaglandin in stock, while minimising waste.”
Genestran 50ml is available in all veterinary wholesalers now.
Technical questions about Genestran should be sent to: vets@fortehealthcare.com
Tom graduated from the Royal Veterinary College (RVC) in 2017 and joined Synergy Farm Health full-time in 2018, after completing his postgraduate diploma (PGDipVCP) with the RVC.
Nominated by his practice, Tom is described as a fine example of a dedicated caring professional who is passionate about sustainability, has a keen sense of his clients’ needs, and has developed strong working relationships with the farms under his care.
The judging panel found that Tom uses data effectively in herd health planning to highlight areas of improvement, working in partnership with his clients to promote disease prevention and profitability.
Tom’s clients spoke of his knowledge and caring attitude and how much he is valued as part of their team.
Tom said: “It was a privilege to be a part of the awards and to see farmers and businesses acknowledged - farmers don’t always get the recognition they deserve and seeing British dairying showcased was amazing.
"I hope winning is reward for the time and effort colleagues at Synergy put into young vets too, and that I can put it to good use supporting clients and working with other organisations within the dairy industry.
"My aim as a vet has been simply to support clients the best I could, both clinically and emotionally, so to have won made it a fantastic night and one I won’t be forgetting!”
The runner up as Charlie Mays of LLM Vets, who the judging panel praised for making effective changes on farm towards preventive healthcare and using data to assist with health and profitability.
Charlie also lobbies government to support the interests of the farmer and the industry.
Sabrina Jordan from Virbac said: ‘Virbac has been supporting dairy vets with products and services for over 50 years and recognise the commitment of young dairy vets to the profession.
"The standard of nominations into this category was outstanding, and our winner and highly commended nominees are a true credit to the veterinary profession, both are shining lights of the future’.
Pooch & Mutt has 20x 40-day trials of its new joint & bone supplement, Mobile Bones Concentrate, to give away to veterinary professionals.
Guy Blaskey from Pooch & Mutt said: "At The London Vet Show vets and vet nurses told us that they loved the new Mobile Bones Concentrate because at just £9.99 per month it costs less than other joint supplements (whilst having the same high quality ingredients), it takes up a very small amount of shelf space and it doesn't involve the client having to either change their dog's food or stuff pills down their dog's throat."
In response to requests from vets and vet nurses to try the new joint supplement, Pooch & Mutt have set up a dedicated website at www.jointsupplementfordogs.com where you can apply from one of twenty 40 day trials.
Guy continued, "We did not want to simply send samples out to everyone. By setting up the site we can choose a variety of dogs from different breed and with different conditions to send a full 40-day trial to. We hope to get regular feedback from the vets, vet nurses and dog owners involved in the trial and publish it on http://www.jointsupplementfordogs.com/ for everyone else to see."
The trials are available to all veterinary professionals and can be for their own dogs, or dogs belonging to their clients.
Zoetis has announced that following a positive opinion from the Committee for Medicinal Products for Veterinary Use (CVMP), the European Commission has approved Apoquel (oclacitinib tablet) in the European Union for the treatment of pruritus associated with allergic dermatitis and the treatment of clinical manifestations of atopic dermatitis in dogs at least 12 months of age.
Developed by Zoetis, Apoquel is the first Janus kinase (JAK) inhibitor approved for veterinary use. The company says it inhibits the function of a variety of allergic, itch and pro-inflammatory cytokines dependent on JAK enzyme activity and thus stops the cycle of itch and inflammation occurring in skin allergies.
Michael Stegemann, Senior Director Global Development Organisation at Zoetis said: "Apoquel is a targeted treatment that specifically inhibits JAK-dependent cytokines involved in allergic skin disease in dogs. Its rapid anti-pruritic effect along with its anti-inflammatory properties provide fast relief to dogs. Relief from itch and inflammation is maintained in dogs receiving long-term treatment with Apoquel. This exciting innovation molecule offers quick, effective, and sustained itch relief; improves skin lesions continuously and can be used safely short or long-term."
Zoetis says that in clinical trials, Apoquel demonstrated safety and efficacy for the treatment of itch and resulted in improved skin lesions in dogs diagnosed with a number of allergic skin diseases as well as atopic dermatitis and treated either short or long term. The decrease in itch scores was observed by pet owners as soon as 24 hours after administration, the first observation time point, and itch continued to decrease compared to baseline until the end of the study. Skin lesions scores assessed by veterinary surgeons were significantly improved after one week and continued to improve long term during the studies (4 months). In these studies, the most common side effects observed in dogs treated with Apoquel were vomiting and diarrhea. Other reported side effects included lethargy, decreased or lack of appetite, skin irritation or infection, and ear irritation or infection.
Apoquel will be a POM-V treatment. Apoquel tablets, dosed at 0.4 to 0.6 mg/kg, are administered orally, twice daily for up to 14 days, and then administered once daily for maintenance therapy if medium to long term treatment is required, such as in dogs with seasonal skin allergy and atopic dermatitis.
Zoetis plans to make Apoquel available to veterinary surgeons in the European Union during 2014. Meantime, Zoetis says it will be working with vets on the new science and research findings around itch and canine allergic diseases. For more information, visit www.zoetis.com, www.itchcycle.com.
The RCVS has announced that it is to trial a new alternative dispute resolution scheme for users of veterinary services who have complaints which aren't serious enough to call into question a veterinary surgeon or nurse's fitness to practice.
The College says that although it is obliged to investigate all complaints, currently it can only deal with the most serious of complaints raised against a veterinary surgeon's or registered veterinary nurse's fitness to practise. This means that many of the 800 or so complaints received every year by the College's Professional Conduct Department are closed with no further action.
Nick Stace, RCVS Chief Executive Officer and Secretary, said: "It was clear from our consultations last year for the First Rate Regulator initiative that many animal owners who had made complaints were dissatisfied and frustrated with the fact that we were unable to take their, often very legitimate, concerns any further.
"It is for this reason that we decided to launch a trial in order to determine how we could develop an alternative scheme that, through conciliation, would try and resolve these disputes in a way that would be acceptable to both parties.
"Although this trial is small-scale we hope that it will provide the framework for a permanent ADR scheme which I believe would both increase consumer confidence in the profession and help maintain and preserve its reputation.
"We hope that the profession will actively support the trial, and any future scheme, as a way of resolving those intractable disputes which we know can hang over veterinary surgeons and practices and that they recognise that, ultimately, what is good for the consumer can be good for the profession."
The trial will be administered by the Ombudsman Services, an independent and not-for-profit complaint resolution service, and limited to no more than 150 concerns raised about veterinary surgeons in regards to the treatment of a small animal. In most cases concerns referred to the trial will have no arguable case for serious professional misconduct. The trial is free to the users and voluntary, and consent will be sought from both parties before the concern is referred to the Ombudsman Services. The costs of the trial will not exceed £120,000.
Recommendations will be determined through conciliation between both parties and the Ombudsman Services will only be able to suggest, rather than impose, a solution that each party is entitled to accept, or not. Solutions could include, for example, financial accommodation up to the small claims court limit of £10,000 (although the average recommendation is around £100), the issuing of an apology or other practical action to remedy the situation.
The Ombudsman Services will be assisted in its investigations by veterinary advisers who will provide guidance on clinical and other veterinary matters.
The results of the trial, which will end in May 2015, will be presented at the June 2015 meeting of RCVS Council where steps will be considered for the development of a permanent scheme.
More details about the trial can be found at www.rcvs.org.uk/adr
Petplan has announced the finalists for the 2011 Petplan Veterinary Awards.
Now in its 12th year, the Petplan Veterinary Awards received its biggest response yet with over 2,800 nominations submitted for exceptional veterinary staff all over the UK.
The finalists for each of the categories are as follows:
Vet of the YearCharles Bagnal, Orwell Veterinary Group - Ipswich Alison Laurie, Crown Vets - Highlands Daniel Parry, Village Vet Garden Suburb - London
Vet Nurse of the YearEmma Clare, Copthorne Veterinary Clinic - Shropshire Maria Corcoran, Orwell Veterinary Group - Ipswich Ingrid Hunt, Cranbrook Veterinary Centre - Devon
Support Staff of the YearBev Millward, Milton Keynes Veterinary Group - Milton KeynesLauren Hunter, The Ferns Veterinary Practice - Dunkeld Patty Fraser, Loch Leven Equine Practice - Kinross
Vet Practice of the YearAshfield House Veterinary Hospital Ltd - Nottinghamshire Emersons Green Veterinary Surgery Ltd - Avon Leonard Brothers Veterinary Centre Ltd - Shropshire
Alison Andrew, Petplan's Marketing Manager, said: "The nominations get bigger and better every year and we're absolutely delighted to announce the finalists for 2011. With 70% of veterinary practices within 3 miles of their patients, veterinary staff are an important part of the community and that's why we feel it important that they have a chance to receive the recognition they deserve. We're looking forward to revealing the winners on 31st of March."
All finalists will be invited to an elegant awards ceremony that will take place on 31st March at the Birmingham Town Hall, where the winners will be announced.
For further information, visit http://www.petplanvet.co.uk/
The Saddle Research Trust has announced the launch of a new paper to help vets understand the significance of saddle fit on the health and welfare of horse and rider.
Saddle fitting, recognising an ill-fitting saddle and the consequences of an ill-fitting saddle to horse and rider was written by equine vet Dr Sue Dyson together with Master Saddlers and saddle fitters Mark Fisher and Sue Carson.
The paper has been published in the Equine Veterinary Education Journal, the official education journal of the British Equine Veterinary Association and is free to view until April 2016.
The paper encourages vets to work as part of a multi-disciplinary team with saddle fitters, trainers and physiotherapists, to help educate horse owners about the multiple problems that can be caused by ill-fitting saddles.1
Key advice includes:
The paper also includes a glossary of saddlery terms, an explanation of saddle fit accessories, a range of informative photographs and a section on who is qualified to provide professional advice on saddle fit.
The paper concludes: “Correct saddle fit for horse and rider is an important equine welfare issue and the veterinary profession needs to recognise this and be at the forefront of helping to educate the horse owning public. Ideally veterinarians should work in conjunction with professional saddle fitters, trainers and physiotherapists to improve both horse and rider comfort.”
Ed's note: If you read the article to which this news story refers, don't forget to come back to VetSurgeon.org and use the 'Claim CPD' button above to add the time spent to your VetSurgeon Personal Development Record.
Mark Colonnese, Aquarium’s Sales and Marketing Director said: "As someone who owns two dogs, the results of the survey have not come as too much of a surprise to me, but I know that some of my colleagues were pretty surprised just how important we think our pets are."
The survey showed that the feelings were even stronger among women, 71% of whom would regard a pet death as equally upsetting to that of a family member’s, compared to 55% of men.
Mark added: "Our results really highlight the sensitivity of issues surrounding a pet’s death. While this would be obvious to, for instance, a life insurance company, our survey reinforces the need for an empathetic customer journey among pet insurers. The first step of this process is ensuring a smooth, seamless process to minimise stress for newly bereaved pet parents."
The dentistry group is one of a number of special interest groups being launched on VetSurgeon.org in the coming months which ALL members are invited to come and join.
The new groups make it much easier to find and follow content that interests you. More than that, they bring together members with a shared interest in the subject, thereby facilitating the sharing of information, experience and knowledge. To that end, expert contributors to the new dentistry group include: Pete Southerden, Norman Johnston, Bob Partridge and Evelyn Barbour-Hill.
As elsewhere on VetSurgeon.org, reading content in the new groups or participating in discussions can count towards a VetSurgeon.org CPD certificate. Just press 'Claim CPD' at the top of the page, then collect the record and certificate from your profile.
As elsewhere on VetSurgeon.org, there's also the opportunity for you to express your appreciation of shared information you've found helpful, by pressing the 'Thank you' button above content. We'll be rewarding those members who are most thanked by members of the site for their help.
The new groups have been set up partly in response to the growth in Facebook groups for vets and the need for VetSurgeon.org to offer added value over Facebook if it is to compete for your attention.
By virtue of the number of its numbers, Facebook probably can't be beaten for general 'chit chat'. But for clinical discussions, it has some serious flaws.
Firstly, there's minimal curation of content and it's more or less impossible to filter irrelevant stuff. Because of that, and because Facebook displays post excepts, rather than headlines, you can end up having to scroll as far as Australia to find stuff relating to your area of interest.
By contrast, the listings of latest content by title on VetSurgeon makes it much easier to scan the content and find the stuff that interests you, particularly now content is grouped by clinical discipline.
Perhaps even more importantly, it's impossible to see the professional qualifications of the person who replied to you on Facebook, so you don't necessarily know if they have the faintest idea what they are talking about. VetSurgeon profiles are visible to all, and allow members to display their postgrad veterinary qualifications, amongst other things.
Lastly, the way discussions on Facebook are 'threaded' makes it very, very difficult to refer back and find who said something useful (you remember someone said something, but then, on a busy thread, you may have to expand 20 or 20 threads to find the thing you were after). That's not just a pain in the derrière, it means that any valuable information shared by specialists and experts is too easily lost.
The bottom line is that if you're looking for general chat, Fleecebook may be your best bet. But if you have questions about specific clinical disciplines, VetSurgeon.org is where you'll find better answers, quicker.
The company says the webinars will equip veterinary professionals with strategies to strengthen wellbeing both individually and for practice teams.
Lauren Hayes, Scientific and Regulatory Affairs Manager at Royal Canin, said: “Working within clinical veterinary practice can be hugely rewarding and enriching, but it cannot be ignored that our industry also has its challenges.
"Veterinary surgeons have a significantly higher risk of suicide compared to the general population and mental health issues around work life balance and compassion fatigue are widespread.
"Through our webinar series, we hope to encourage conversations around mental health and help provide advice directly from leading experts.”
The one-hour webinars will take place at 7pm every Wednesday throughout September.
https://vetportal.royalcanin.co.uk/news/new-veterinary-professional-health-webinar-series/
Certified B Corps are companies that meet exceptionally high standards of social and environmental performance, transparency and accountability.
The process examines a company’s full range of processes, from supply chain to charitable giving and employee benefits.
Other well-known names that have achieved B Corp status include Patagonia, The Body Shop, BrewDog, TOMS, Ben and Jerry’s and Innocent Drinks.
Dr Caroline Collins, from Pennard Vets, said: “We’re extremely proud to achieve B Corp status and there’s no doubt that it will be transformational for the business, in the same way that becoming an employment ownership trust has been.
"Being employee owned and socially minded is a huge draw for vets and nurses seeking a change in their career, who want to be part of an organisation where they can have a real say in the running of the practice and make a tangible difference to the environment.
“It also means that we can now make very long-term decisions, that could even take several decades to pay off, which would be very difficult to do in a traditional shareholder business, and that gives our team the authority to always do the right thing.”
Enalees offers a variety of point-of-care isothermal PCR animal diagnostics tests for canine, feline and equine infectious diseases, including parvo, leptospirosis, babesiosis and borreliosis.
The company says its tests are highly specific and sensitive and can detect the presence of a virus, parasite or microbe at a very early stage, without the use of expensive and complex equipment, within 30 minutes.
Lauren Craig is the General Manager of the new subsidiary. She said: “I will be coordinating the launch of the UK subsidiary and working with veterinary professionals to deliver Enalees’ unique portfolio offering in diagnostic testing and in clinic rapid PCR tests.
“I am incredibly excited for the challenge ahead and looking forward to working with a fantastic team with an important mission in this key market.”
www.enalees.com
For the study, 12 month's worth of anonymised data from CVS practices was analysed2.
The study concluded that lower engagement between a practice and its staff or clients, recent parental leave, shorter practice employment tenure, and younger age were all associated with an increased likelihood of support staff resignations.
Lower practice client engagement, which CVS says is a proxy for client satisfaction, was associated with increased odds of support staff resigning3, highlighting the potential impact of client incivility on veterinary colleagues who are typically in customer facing roles.
Reduced employee engagement – measured by a ‘employee net promoter score’ (eNPS), where colleagues rate how likely they would recommend the practice as a good place to work4, also correlated with increased resignations.
Within CVS, eNPS has been demonstrated to be positively correlated with the frequency of line manager discussions.
The current data suggests that consistent measurement of employee engagement in a veterinary setting at regular intervals throughout the year can have benefits for line managers in identifying increases in the risk of resignations and practice attrition, allowing them to take proactive steps to improve engagement.
A recent record of taking parental leave was also associated with greater odds of resigning in the following 12 months than staff who have not taken parental leave in the previous 12 months5.
Qualitative studies in other professions highlight the need for greater flexibility in working hours and focused managerial check-in support.
Therefore ‘return to work’ interventions may present an opportunity to improve retention.
Conversely, the increased length of employment tenure was associated with decreasing odds of support staff resignations6, potentially highlighting the role for long service reward schemes, such as the long service holiday awards CVS introduced a couple of years ago. Whilst employee age was associated with the odds of resignations, with a 1% decrease in the odds of support staff resigning with each additional year of age7.
Imogen Schofield, Director of Clinical Research at CVS, said: “Support staff are integral members of the team.
"These key roles contribute to the efficient and effective functioning of a veterinary practice.
"Despite the important roles of support staff, little research exists on these team members and there is no data describing reasons for their attrition.
“This research was done to help the wider industry to understand how we can reduce support staff resignations.
"It aims to identify demographic, payroll and engagement factors associated with resignations.
"We believe it adds valuable insights to previous survey-based research by organisations such as the British Veterinary Receptionist Association.
“Reflecting on our research from 2021, we have introduced a Zero Tolerance Policy to protect our colleagues against intrusive, offensive, violent or aggressive behaviour from clients.
"We have launched monthly interactive Receptionist Support Sessions, giving receptionists the opportunity to connect with their peer network, share experiences and ideas, and feel supported.
"And we are now focussing on developing our support staff through creating new Receptionist and Patient Care Assistant Career Pathways.”
References
The two companies have agreed to jointly discover and develop species-specific therapeutic monoclonal antibodies for companion animals, a class of drug which they say is neglected in veterinary medicine but offers a variety of future therapeutic options for diseases that cannot be adequately treated today.
adivo will select species-specific antibodies using its proprietary fully canine phage display library. Bayer Animal Health will provide targets involved in severe animal diseases.
Dr. Douglas Hutchens, Bayer Animal Health’s Head of Drug Discovery, External Innovation & Chief Veterinary Officer, said: "Today’s agreement is another example of how we realize our innovation strategy
"By combining the know-how from creative start-up companies like adivo with opportunities derived from Bayer’s research, we broaden our space of therapeutic medicine options and complement our portfolio.
"We are constantly looking for innovative technologies that enable us to generate novel treatment options for the companion animal sector. Now, we will focus on evolving the options presented by adivo from research and development to market maturity."
Dr. Kathrin Ladetzki-Baehs, Managing Director of adivo said: "At adivo, we truly believe that pets have a positive impact on our society. By developing novel medicines for companion animals, we want to make a difference for veterinarians and pet-parents. Today, we are more than pleased and excited to have gained such a committed and experienced collaboration partner, to jointly develop new treatment options."
The Association says it has produced the leaflet after seeing an increasing number of dogs diagnosed with clinical or subclinical infection, along with reports of its zoonotic impact.
The document outlines the most important considerations concerning B. canis including transmission, diagnosis, management, public health implications and legislative requirements.
It takes into consideration information available from relevant Government Departments.
BSAVA says the document is by no means exhaustive but is intended to provide useful information and signpost to further resources.
www.bsavalibrary.com/brucella_canis
Photo: Walker16/Wikipedia. CC BY-SA 4.0.